Who Survives Mesothelioma and Why?
A new study of National Cancer Institute data aims to better understand who survives mesothelioma and why. Malignant mesothelioma is a highly aggressive cancer of internal membranes. Very few people diagnosed with mesothelioma live longer than 18 months. But researchers around the world are working to change those odds. One important step is to look at the characteristics of those who live longest with the asbestos cancer. NCI Data Shows Who Survives Mesothelioma Scientists at Mount Sinai Medical Center in New York turned to the National Cancer Institute database to get a better picture of who survives mesothelioma. The database contains information reported by mesothelioma doctors from around the country. It includes information about the ages, gender, lifestyle, mesothelioma type, … Continue reading Who Survives Mesothelioma and Why?
Ginsburg’s Recovery Shows Value of Healthy Lifestyle for Mesothelioma Survival
Justice Ruth Bader Ginsburg’s successful lung cancer surgery illustrates the value of healthy lifestyle for mesothelioma survival. Although Ginsburg did not have mesothelioma, people battling the asbestos cancer would do well to pay attention. The 85-year-old Supreme Court justice recently had two nodules removed from her left lung. Her lung cancer was in an early stage. Doctors say they were able to remove all signs of cancer and Ginsburg is now recovering at home. Ginsburg’s Regular Exercise Routine Justice Ginsburg has survived cancer twice before. She had colon cancer in 1999 and pancreatic cancer in 2009. In both cases, she bounced back quickly. She did not miss a day on the bench. Ginsburg is known for her healthy lifestyle. She eats … Continue reading Ginsburg’s Recovery Shows Value of Healthy Lifestyle for Mesothelioma Survival
Mesothelioma Staging May be Easier with New Approach
Japanese researchers have introduced a new approach to mesothelioma staging. The new system may make it easier to plan treatment and predict mesothelioma prognosis. Tumor staging is a system for measuring how far cancer has spread in the body. It is based on what doctors know about how cancer develops and grows. The more places mesothelioma cells are, the more difficult the case is to treat. The TNM Staging System is the most widely used system for mesothelioma staging. The American Joint Committee on Cancer established the system. In the TNM system, T stands for the size of the primary mesothelioma tumor. N stands for the spread of cancer to the lymph nodes. M is about cancer spread to other … Continue reading Mesothelioma Staging May be Easier with New Approach
Combination Therapy with Mesothelioma Surgery Leads to Longer Survival
A new study finds almost a quarter of people who had combination therapy with mesothelioma surgery were still alive five years later. The study was published in the European Journal of Cardio-Thoracic Surgery. Researchers at University Hospitals KU Leuven in Belgium studied nearly 200 mesothelioma patients from 2003 to 2014. Many people do not live beyond about 18 months after a mesothelioma diagnosis. But the Belgian team says, for the right patients, there is a way to improve the odds. They say combination therapy with radical mesothelioma surgery offers a 1 in 4 chance of surviving for 5 years or more. Two Types of Mesothelioma Surgery There are two major schools of thought about mesothelioma surgery. Some surgeons say it … Continue reading Combination Therapy with Mesothelioma Surgery Leads to Longer Survival
Japanese Discovery Could Lead to New Mesothelioma Blood Test
A discovery in Japan could lead to a more effective mesothelioma blood test for mesothelioma diagnosis. Japanese scientists say they have found a better way to detect mesothelioma cells in the blood. The scientists are experts in occupational health. Malignant mesothelioma is an occupational cancer because people can get it from working near asbestos. Mesothelioma diagnosis is challenging. But a powerful mesothelioma blood test could make it easier to find the asbestos cancer earlier. Treatment often works better when patients start it earlier. Circulating Tumor Cells in the Blood of Mesothelioma Patients No matter what kind of cancer a person has, their tumor releases some cells into the blood. Mesothelioma tumors are no exception. These circulating tumor cells (CTCs) are … Continue reading Japanese Discovery Could Lead to New Mesothelioma Blood Test
Meta-Analysis Finds Lung-Sparing Surgery the Best Option for Most Mesothelioma Patients
There is now more evidence to support the growing number of experts who favor lung-sparing P/D surgery over radical extrapleural pneumonectomy (EPP) for the treatment of malignant pleural mesothelioma. There has been an ongoing debate within the surgical community over which procedure carries the most benefit with the least risk. The late David Sugarbaker, MD, of Baylor St. Luke’s Medical Center in Houston was a pioneer of the EPP procedure, which involves removing not only the diseased pleural lining where mesothelioma tumors grow, but also the nearest lung, most of the diaphragm, the pericardium, and other at-risk tissues. But it turns out that, although Sugarbaker and his team were able to show a mesothelioma survival benefit with EPP, their results, … Continue reading Meta-Analysis Finds Lung-Sparing Surgery the Best Option for Most Mesothelioma Patients
Ofev Fails to Boost Mesothelioma Survival in New Study
In the quest to develop new, more effective first-line treatments for malignant pleural mesothelioma, it now looks like Ofev (nintedanib) is out of the running. Phase III results of the LUME-Meso mesothelioma trial are in and they contain some disappointing news for mesothelioma patients and for the drug’s developer, Boehringer Ingelheim. The news is especially disappointing since the results of the Phase II portion of the trial, released last year, looked promising. At that time, researchers reported a survival gain of more than 5 months among the Ofev-treated mesothelioma patients and progression-free survival of four months. But further research did not support those results, as investigators announced to the world’s lung cancer experts at the IASLC 19th World Lung Cancer … Continue reading Ofev Fails to Boost Mesothelioma Survival in New Study
A Less Formal Approach to Connecting Mesothelioma Patients and Researchers
Mesothelioma researchers in England are experimenting with an innovative way to connect patients and scientists in the quest for a cure. Malignant mesothelioma, the cancer most closely associated with asbestos exposure, is one of the world’s most deadly malignancies. Many patients diagnosed with mesothelioma are given only months to live. Increasingly, clinical research holds great promise for new ways of approaching diseases like mesothelioma, but understanding that research and its implications can be difficult, even when listening to the researchers directly. To bridge the gap, investigators with the June Hancock Mesothelioma Research Fund (JHMRF) in Sheffield, UK have introduced “Meet the Researchers” — a program designed to engage mesothelioma patients and researchers in a more informal way. Mesothelioma Research Can … Continue reading A Less Formal Approach to Connecting Mesothelioma Patients and Researchers
How Doctors Break Bad News May Impact Mesothelioma Survival
For newly diagnosed mesothelioma patients, having a doctor who is too compassionate could have a negative impact on their survival. Researchers at France’s University of Lille made that seemingly counterintuitive observation as part of the first study of the prognostic role of physician empathy in cancer patients. The results, published in the Journal of Clinical Medicine, suggest that, rather than comforting patients, too much compassion and listening from the oncologist tends to make them worry more about their odds of survival. Physician Attitude and Mesothelioma Outcomes The study involved 179 patients who were diagnosed with lung cancer or pleural mesothelioma between January 2015 and March 2016. Both cancers are difficult to treat and often carry a poor prognosis. This is … Continue reading How Doctors Break Bad News May Impact Mesothelioma Survival
Lung Fluid Proteins Could be Key to Earlier Mesothelioma Diagnosis
Australian researchers say proteins found in lung fluid could hold the key to diagnosing pleural mesothelioma months or even years before a tumor is visible on imaging scans. Proteins function as communication devices in the body, directing all sorts of critical cellular processes, including the processes that tell cancer cells to begin replicating at a higher rate than normal cells. Scientists at Flinders University, one of the world’s leaders in mesothelioma research, wondered if the proteins that help give rise to malignant pleural mesothelioma could be found in pleural effusions and used as biomarkers to identify the cancer earlier. Looking for Mesothelioma Biomarkers in Lung Fluid In a new study published in the Journal of Proteomics, the team notes that … Continue reading Lung Fluid Proteins Could be Key to Earlier Mesothelioma Diagnosis
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."
Get your free copy of
“Surviving Mesothelioma” Today!